LXEO logo
Lexeo Therapeutics, Inc. Common Stock(LXEO)
Last print unknown agoAbout this dataData status
$2.76▲0.12 (4.55%)Stale · unknown old

LXEO Total Non-Current Liabilities

$4.15MQuarterly · USD

Period ending:

LXEO FY Total Non-Current LiabilitiesUSD
LXEO FY Total Non-Current Liabilities2020-12-31: $34.25M2021-12-31: $185.01M2022-12-31: $195.68M2023-12-31: $9.03M2024-12-31: $7.25M2025-12-31: $5.21M$195.68M$0.00
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LXEO total non-current liabilities history

Long-term obligations due beyond one year. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Lexeo Therapeutics Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)
5,211,000
7,254,000
9,033,000
195,681,000
185,013,000
34,247,986

Compare total non-current liabilities

All LXEO financial metrics · LXEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.